After grabbing 1.65 million shares, the institutional investor is now in possession of 1.65 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 4.26% having worth around $5.55 million. Moreover, SSgA Funds Management, Inc. increased its share by 0.43 million to have a control over 0.43 million shares. And The Vanguard Group, Inc. raised its holdings to 87136.0 shares by acquiring 0.38 million shares or 0.99% of the stake.

Genprex Inc. (GNPX) concluded trading on 08/27/20 at a closing price of $3.92, with 1.01 million shares of worth about $3.96 million changed hands on the day. Weekly performance of the stock remained positive as price took a surge of 0.77% during that period and on Thursday the price saw a gain of about 1.55%. Currently the company’s common shares owned by public are about 35.36M shares, out of which, 31.32M shares are available for trading.

A deeper look into what the analysts at Wall Street are thinking about the price target of this stock provides us with the following: 1 analyst is covering the GNPX stock and their offered price forecasts bring an average price target of $7.00. Over the next 12 months, analysts forecasted that the stock’s price could jump as high as $7.00 and could fall to a lowest price of $7.00. Analysts also issued an outlook of 2.00 for the Genprex Inc. stock for next 12 months. However, touching the estimated high of $7.00 would mean a gain of 44.0% for the stock.

According to filings with the U.S. Securities and Exchange Commission (SEC), insiders took part in trade of the company’s stock for 1 times over the past 12 months. They bought 1,800 shares in 1 of the transactions. In 0 selling transactions, insiders dumped 0 shares.

iShares Russell 2000 ETF, Vanguard Extended Market Index Fu, and iShares Russell 2000 Growth ETF are the top 3 mutual funds which are holding stakes in Genprex Inc. iShares Russell 2000 ETF is currently holding 0.6 million shares of worth totaling $2.03 million. The company recently came selling 28084.0 shares which brought its stake up to 1.56% of the company’s outstanding shares. iShares Russell 2000 Growth ETF, after selling 0.26 million shares, have now control over 0.68% of the stake in the company. It holds 2584.0 shares of worth $0.89 million.

Genprex Inc. (NASDAQ: GNPX) started trading at $3.91, above $0.05 from concluding price of the previous day. However, the stock finished the trading on the day at a closing price of $3.92, or with a gain of 1.55%. Stock saw a price change of 0.77% in past 5 days and over the past one month there was a price change of 12.97%. Year-to-date (YTD), GNPX shares are showing a performance of 1125.00% which increased to 340.45% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.23 but also hit the highest price of $7.03 during that period. While comparing its average daily trading volume of 1.80 million shares, we see that about 1.01 million changed hands on the day. The stock is currently trading 3.96% above its 20-day simple moving average (SMA20), while that difference is up 13.46% for SMA50 and it goes to 66.03% higher than SMA200.

BlackRock Fund Advisors acquired 1.65 million shares of Genprex Inc. having value of about $5.55 million. Genprex Inc. (NASDAQ: GNPX) currently have 35.36M outstanding shares and institutions hold larger chunk of about 18.10% of that. Holding of mutual funds in the company is about 4.67% while other institutional holders and individual stake holders have control over 8.46% and 17.36% of the stake respectively.

The stock has a current market capitalization of $155.98M. It has posted earnings per share of -$0.61 in the same period. It has Quick Ratio of 97.00 while making debt-to-equity ratio of 0.00. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for GNPX, volatility over the week remained 10.33% while standing at 9.06% over the month.

Analysts are in expectations that Genprex Inc. (GNPX) stock would likely to be making an EPS of -$0.15 in the current quarter, while forecast for next quarter ESPS is -$0.19 and it is $0.25 for next year. For the current quarter EPS, analysts have given the company a lowest target -$0.21 which is -$0.09 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of -$0.14 in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 26.00% while it is estimated to increase by 158.10% in next year.

Analysts at 1 brokerage firms have issued recommendations for the Genprex Inc. (GNPX)’s stock and average of those rates the stock at a “Moderate Buy” and assign it a score of 2.00. Out of those 1 Wall Street analysts, 1 recommended a “Buy” rating, while 0 were in favor recommending the stock as a “Hold” and 0 analyst recommended the stock as “Sell”.

Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Noble Capital Markets on April 29, 2019 offering an Outperform rating for the stock and assigned a target price of $5 to it.